Jim Tananbaum explains that $14m Raised by Mindstrong will improve patients’ outcomes

Mindstrong Health, an organization that uses Smartphones to measure brain function, recently received $14 million from investors. Foresite Capital’s CEO, Jim Tananbaum noted that the founders of Mindstrong Health understand the difficulties that face medics treating patients with cognitive health disorders and explained that the funding would help them create an innovative platform for medics treating patients with cognitive disorders. They received the money for investors that include ARCH Venture Partners, Optum Ventures, and Foresite Capital.

 

How the platform works

 

Mindstrong’s technology analyzes patients’ cognitive functions by evaluating how they type and scroll their smartphones. According to Wired.com, the doctors then use this information to measure brain activity. The platform provides data on mood and brain activity biomarkers such as memory and function. It delivers the objective measures at a higher resolution and insight, making it easier for doctors to use measures such as those used for diseases like diabetes and cardio vascular diseases. Measurements for cognitive disorders were previously based on subjective studies carried out in clinical surroundings. According to Mindstrong’ s Health co-founder, Dr. Tom Insel, this assessment approach is only the beginning of development of better tools to be used in caring for mentally ill patients. Since smartphones are available globally, the platform can be used to treat patients everywhere.

 

About Jim Tananbaum

 

Jim Tananbaum (http://www.officialjimtananbaum.com/) has over two decades experience in investing and developing health companies. He is currently the CEO and Managing Director of Foresite Capital. After graduating from Harvard Medical School, Jim Tananbaum founded GelTex Pharmaceuticals. The company marketed two drugs that brought in around $80 million; the drugs currently make $1 billion. GelTex was sold at $1.6 billion.

 

Tananbaum also co-founded Prospect Venture Partners and Theravance where he was also CEO. Theravance and Theravance Inc. together generated $2.75 billion. He also served at Sierra Venture and headed other organizations including Amira Pharmaceuticals, Jazz Pharmaceuticals and Healtheon and Amerigroup (IPO).Tananbaum holds a B.S and a B.S.S.E from Yale University. He also has a medical degree and M.B.A from Harvard and a M.S from MIT. He served as a member of advisory boards and visiting committees at Harvard, MIT and Yale.

 

Read More: https://ideamensch.com/jim-tananbaum/

 

Equities First Holdings Registering Rapid Growth Worldwide

From 2002, Equities First Holdings has been providing customers with alternative financing solutions by using open traded stock as collateral. With nine offices operating in different continents, the company has extended services near its customers. To date, Equities First has completed over 700 transactions which are valued over $1.4 billion USD. The global organization has fully owned auxiliaries in Hong Kong, London, Australia, Singapore and South Africa among other places.

The company provides stock loans to high asset worth individuals and small businesses. Its headquarters are in Indianapolis and operates another satellite facility in New York. Equities First fastened its growth in 2013 by partnering with Meridian Equity Partners, a global investment and admonitory organization situated in Sydney and London. The EFH operates other offices in Jakarta, Singapore, Bangkok, Hong Kong and South Africa.

In 2013, Equities First enhanced its base camp size within Indianapolis and expanded its operations and investment management staff. The top-notch organization’s team was built to provide good customer care services, and today it has continued to invest its functions with the company developing quickly. Equities First takes pride in longtime partners who entail the world’s largest custodian banks, top tier investment banks and top law firms at local and global levels.

In today’s world, small businesses are finding it hard to borrow traditional loans with most of the institutions tightening lending conditions. The interest rates are also high, and merits are minimal compared to alternative lending services. At Equities First borrowers enjoy fast loans that come with fixed and low-interest rates. They also benefit from the non-recourse feature where borrowers can stop repaying their loans and leave their security with the lender and non-purpose feature benefit where investors can use borrowed loans as their desire. For more information, you can visit http://www.otcmarkets.com/stock/ANPCY/news?id=143461 and get to know more of the great benefits of stock-based loans.